Comprehensive online GMP training aligned with EU GMP Guidelines (EudraLex, Volume 4), EMA, and ICH standards — trusted by European pharmaceutical manufacturers, quality professionals, and auditors. Self-paced. 21 CFR Part 11 compliant certificates. Inspection-ready training records for EMA and national competent authority audits.
The European Union has a highly structured GMP framework, primarily governed by the European Commission's EudraLex, Volume 4, which contains the EU GMP guidelines for medicinal products for human and veterinary use. These guidelines are legally binding and enforced by the European Medicines Agency (EMA) and national competent authorities. The framework is based on Directive 2003/94/EC and is heavily influenced by ICH guidelines, including ICH Q7 for APIs. EU GMP is considered a global gold standard, and all manufacturers of medicinal products in the EU must be in full compliance.
Key Regulatory Frameworks:
EudraLex Volume 4 (EU GMP Guidelines) – Primary GMP guidelines for medicinal products.
Directive 2003/94/EC – Lays down the principles and guidelines of GMP.
EU GMP Annexes – Specific requirements for different product types (e.g., Annex 1 for sterile products).
ICH Q7 – Good Manufacturing Practice Guide for APIs.
21 CFR Part 210 & 211 – Essential for companies exporting to the U.S.
| Market | Authority | GMP Framework |
|---|---|---|
| UK (domestic) | MHRA | UK GMP — Human Medicines Regulations 2012 |
| European Union | EMA | EudraLex Volume 4, EU GMP |
| United States | US FDA | 21 CFR Parts 210 & 211, cGMP |
| Global / WHO Prequalification | WHO | WHO GMP guidelines |
| API Manufacturing | ICH | ICH Q7 |
All courses are self-paced, available online, and include 21 CFR Part 11 compliant certificates with verifiable IDs — accepted as documented training records during regulatory inspections.
This training program defines the complete knowledge and performance requirements for personnel involved in pharmaceutical manufacturing to become certified auditors for Good Manufacturing Practice (GMP) in the European Union regulatory environment. The program integrates EU GMP requirements from EudraLex Volume 4 (Part I: Basic Requirements for Medicinal Products, Part II: Basic Requirements for Active Substances, and relevant Annexes) with auditing practices based on ISO 19011:2026 for internal, second-party (vendor, CRO, and supplier) audits and global regulatory compliance auditing.
The participant learns what EU GMP requires across all aspects of pharmaceutical manufacturing, how to audit those requirements, and how to conduct audits across multiple jurisdictions and organizational boundaries. ISO 19011:2026 provides the methodological framework for planning, conducting, reporting, and following up on audits. The standard covers audit principles, audit programme management, the conduct of management system audits, and the evaluation of auditor competence.
This refresher course focuses on critical updates, high-risk areas, common inspection findings, and advanced application of GMP principles in day-to-day operations. Rather than re-teaching basic concepts, this program reinforces essential knowledge while introducing new regulatory expectations and industry best practices. For UK professionals, the content is directly applicable to MHRA inspection readiness and aligns with the Orange Guide requirements .
Enroll in EU GMP TrainingThis comprehensive training program is based on the EU GMP Guidelines (EudraLex, Volume 4) and the UK MHRA Orange Guide , designed to provide pharmaceutical and biotechnology manufacturing personnel with a thorough understanding of Good Manufacturing Practice principles, requirements, and practical applications. The training covers Part I: Basic Requirements for Medicinal Products, along with key annexes relevant to sterile products, biological products, and radiopharmaceuticals.
Enroll in EMA Focused TrainingThis specialized training program provides in-depth coverage of EU GMP Annex 1 requirements for the Manufacture of Sterile Medicinal Products. The curriculum covers the Contamination Control Strategy, cleanroom classification, barrier technologies, sterilization methods, aseptic processing, environmental monitoring, and personnel requirements .
Enroll EU GMP Annex 1 TrainingThis comprehensive training program offers an in-depth exploration of the complex and rapidly evolving field of Advanced Therapy Medicinal Product (ATMP) manufacturing. Designed to bridge the gap between scientific innovation and regulatory compliance, the curriculum guides participants through the entire product lifecycle, from foundational science and supply chain logistics to the critical principles of facility and cleanroom design .
Enroll in Advanced Therapy Medicinal Products (ATMPs) TrainingThis program provides comprehensive training on cleanroom operations, environmental monitoring, and validation requirements for pharmaceutical manufacturing environments. The curriculum covers cleanroom classification, HVAC systems, contamination control strategies, and regulatory requirements for aseptic processing areas.
Enroll in Certified Cleanroom Operations TrainingThis training program provides comprehensive knowledge of cleanroom design, construction, and operational requirements based on ISO 14644 standards. The curriculum covers cleanroom classification, airflow principles, HVAC systems, contamination control, and environmental monitoring strategies.
Enroll in Cleanroom Design and Operations TrainingThis training program provides comprehensive knowledge of World Health Organization GMP requirements for pharmaceutical products. The curriculum covers WHO GMP guidelines, quality management systems, facility and equipment requirements, production controls, and quality control procedures .
Enroll in Cleanroom Design and Operations TrainingThis training program provides comprehensive knowledge of GMP requirements specific to herbal medicinal products. The curriculum covers EU GMP Annex 7 requirements, Good Agricultural and Collection Practice (GACP), supplier qualification, contaminant testing, and quality control for botanical materials.
Enroll Good Manufacturing Practices TrainingThis training program provides comprehensive knowledge of quality management system requirements for medical devices. The curriculum covers ISO 13485, FDA QMSR, and EU MDR requirements for design control, production, and post-market surveillance.
Enroll in Medical Devices QMS TrainingThis training program covers the complete body of knowledge required for analytical method validation in pharmaceutical, biotechnology, and medical device industries.
Enroll in Analytical Method Validation TrainingThis training program provides comprehensive knowledge of Computerized System Validation (CSV) and GAMP 5 principles for regulated industries. The curriculum covers risk-based validation approaches, system lifecycle management, 21 CFR Part 11 compliance, and Annex 11 requirements.
Enroll Global CSV and GAMP TrainingThis training program provides comprehensive knowledge of CMC requirements for pharmaceutical and biological products. The curriculum covers drug substance and drug product characterization, specifications, stability studies, and regulatory submission requirements for CMC sections of INDs, NDAs, and BLAs.
Enroll Chemistry, Manufacturing and Controls (CMC) TrainingThis training program equips the learner with comprehensive, end-to-end knowledge of the manufacturing, quality control, regulatory compliance, and supply chain management of Chimeric Antigen Receptor T-cell (CAR-T) therapies. Upon completion, the learner will be able to independently apply global current Good Manufacturing Practice principles to autologous cell therapy products .
Enroll CAR-T Cell Therapy TrainingThis program encompasses the full spectrum of regulatory requirements and manufacturing processes governing cell-based products, gene therapy products, and genetically modified cell products . Participants will be able to interpret and apply global regulatory requirements from the FDA, EMA, and Health Canada for CGT product manufacturing, design chemistry, manufacturing, and control strategies that satisfy multiple jurisdictional expectations, and evaluate manufacturing changes and execute comparability assessments that withstand regulatory scrutiny across regions.
Enroll Cell and Gene Therapy Manufacturing TrainingThis training program provides comprehensive knowledge of the modern, lifecycle-based approach to pharmaceutical process validation. It moves beyond the traditional "three-batch mentality" and establishes the scientific, risk-based framework needed to design, qualify, and continuously verify robust manufacturing processes .
Enroll Pharmaceutical Process Validation TrainingThis training program provides a thorough understanding of the principles, processes, and good practices for effective technology transfer in the pharmaceutical industry. The course covers the complete technology transfer lifecycle from initial planning through project close-out .
Enroll Pharmaceutical Technology Transfer TrainingThis training program explores the world of radiopharmaceutical manufacturing, blending practical sterile production techniques with the regulatory expectations that shape every step. You will move from understanding what radiopharmaceuticals are, through facility design and aseptic processing, to quality control, documentation, and the release of both conventional and positron-emitting products.
Enroll Radiopharmaceutical Manufacturing TrainingThis training program provides pharmaceutical professionals with a comprehensive understanding of cleaning validation principles, practices, regulatory requirements, and scientific approaches, all essential to ensuring patient safety and product quality.
Enroll Cleaning Validation in Pharmaceutical TrainingGMP training is a fundamental requirement for all personnel involved in the manufacturing, testing, packaging, and quality control of medicinal products in the EU. This includes:
One of the most important GMP-specific roles in the UK and EU is the Qualified Person (QP). Under both UK GMP and EU GMP, every manufacturer's licence holder must have at least one named QP who is personally responsible for certifying that each batch of medicine complies with GMP and the relevant marketing authorisation before release to market.
The QP role is a legal requirement — not a professional designation. Without a named QP, a UK manufacturer's licence cannot be granted or maintained.
Our GMP training courses support QPs and QP-in-training candidates in meeting their ongoing Continuing Professional Development (CPD) obligations under both UK GMP and EU GMP — including content on QP responsibilities, batch certification, and the regulatory frameworks QPs must remain current on.
The MHRA conducts routine GMP inspections of UK-licensed manufacturing sites. Inspection findings are published in compliance reports. Our training directly addresses the most common MHRA inspection deficiencies.
Inadequate or undocumented personnel training is among the most frequently cited MHRA inspection findings. Our certificates provide auditable, 21 CFR Part 11 compliant records that MHRA inspectors accept.
Data integrity concerns — paper records without contemporaneous entries and audit trail gaps — are a priority MHRA inspection focus. Our course includes a dedicated data integrity module covering ALCOA+ and Annex 11.
Deviation and CAPA management failures are a recurring MHRA observation. Our training covers structured deviation investigation, root cause analysis, and effective CAPA design and verification.
Equipment qualification and validation deficiencies are regularly cited. Our course covers IQ, OQ, PQ, and process validation requirements aligned with Annex 15 and MHRA expectations.
Environmental monitoring gaps for sterile and aseptic manufacturing are a specific MHRA focus. Our EU GMP course covers the revised Annex 1 (2022) requirements in detail.
UK facilities supplying the EU market must maintain dual compliance — UK GMP and EU GMP. Our courses cover both frameworks so your team understands where obligations differ.
Training your entire QA, production, or engineering team? We offer group enrollment for UK pharmaceutical and biotech companies of all sizes — from specialist CMOs to large integrated manufacturers. Group quotes provided within 24 hours.
| Feature | GxP Trainings |
|---|---|
| UK GMP (MHRA) aligned | |
| EU GMP EudraLex Volume 4 aligned | |
| FDA 21 CFR Parts 210 & 211 aligned | |
| PIC/S GMP principles covered | |
| ICH Q7 (API GMP) covered | |
| QP responsibilities covered | |
| Data integrity / ALCOA+ training | |
| 21 CFR Part 11 compliant certificate | |
| Self-paced — study on your schedule | |
| Instant certificate download | |
| Verifiable certificate ID | |
| Group / corporate enrollment |
Yes. The EMA and national competent authorities expect documented, role-appropriate training. Our 21 CFR Part 11 compliant certificates provide verifiable proof of training accepted during inspections.
Regular refresher training is a regulatory expectation. Many organizations require annual refreshers to ensure personnel are up-to-date with the latest guidelines and inspection findings, which our refresher courses are designed to provide.
Both are aligned with ICH Q7 for APIs and share many principles, but there are key differences in specific requirements, documentation, and Annexes (like Annex 1). Understanding both is critical for global companies.
Yes. We offer corporate and group enrollment options for teams of all sizes. Contact us for a custom quote.
All courses include lifetime access — study at your own pace, on your own schedule.
Yes. Each certificate includes a unique verifiable ID that can be checked at gxptrainings.com/verify-certificate/
Equip yourself and your team with the GMP knowledge and documented training records required for MHRA, EMA, and FDA inspection readiness.